Slide 1: 2017 nine-month & third-quarter sales
25.10.2017 2017 nine-month & third-quarter sales Webcast presentation for investors, analysts & media Basel, 26 October 2017 Disclaimer This presentation contains certain forward-looking statements that reflect the current views of management. Such statements are subject to known and unknown risks,
Slide 2: 9-months highlights
25.10.2017 9-months highlights Marco Gadola, CEO Growth throughout and beyond our space REVENUE GROWTH TOP PERFORMER BUSINESS DRIVERS +15% organic1 North America Total solutions Q3: +16% organic; +21% in CHF …generates >30% of Group’s 9M growth; Implants contribute two thirds of 9M growth: 9M: +15%
Slide 3: Momentum sustained in Q3 with accelerations in APAC and LATAM
25.10.2017 Momentum sustained in Q3 with accelerations in APAC and LATAM Growth year-on-year (in %) North America EMEA 28% of Group 44% of Group APAC 17.0 17.2 17% of Group 9.9 10.0 27.9 24.2 Q3 9M Q3 9M LATAM 11% of Group Q3 9M Straumann Group 18.9 15.7 15.9 14.8 Q3 9M 5 Q3 9M Consistently outperfo
Slide 4: Business and regional review
25.10.2017 Business and regional review Peter Hackel, CFO Further expansion across all regions Revenue development (CHFm, rounded) Regional share of organic growth 18.7% 14.8% CHF organic 12% LATAM 12.2 801.3 27.0 32.4 26% 31.9 APAC 16.7 697.8 675.1 6.0 31% North Change in organic growth America 10.
Slide 5: EMEA and North America maintain pace; Asia Pacific and Latin America on fast track
25.10.2017 EMEA and North America maintain pace EMEA Revenue change (organic) EMEA performed consistently throughout 56% the first 9-months 11.1% Germany was the main contributor, with 10.1% 9.9% 9.9% Iberia, France, Belgium and the UK 44% of Group 7.7% 8.0% delivering the strongest increases
Slide 6: Capacity expansion to meet growing demand
25.10.2017 Capacity expansion to meet growing demand Output Facility 2017 2018 2019 increase1 Villeret (CH) New production building (brownfield) +70% Andover (US) +60% Curitiba (BR) +35% +50% space New production area in Curitiba Impression of new production building in Villeret New building/ Additi
Slide 7: Strategic priorities of the Straumann Group
25.10.2017 Strategic priorities of the Straumann Group Drive our high performance STMN Group culture and organization Target unexploited growth markets & segments Expand scope to become a Total Solution Provider for esthetic dentistry 13 Geographical expansion reflected in an increasingly diverse te
Slide 8: New subsidiaries in Iran, Turkey & South Africa
25.10.2017 New subsidiaries in Iran, Turkey & South Africa – direct access to large growth markets Iran Distribution taken over Broader presence; multi-brand strategy 62 Straumann products available in Iran since 2007 (500 000) Turkey Preparations to establish subsidiary in coming months I
Slide 9: Other significant regulatory approvals and launches
25.10.2017 Other significant regulatory approvals and launches Russia Straumann® Bone Level Tapered implant approved India All Straumann® Soft Tissue Level & Bone Level implants approved Major launch event in Mumbai early December Group now offers a comprehensive range of premium & attra
Slide 10: New products and data on SLActive implant surface
25.10.2017 EAO in Madrid New products despite big launch program at IDS Straumann P-Series 3D printers enter market Dental Wings’ powder-free intraoral scanner handpiece Straumann® Surgical Motor Pro Clinical endorsements for Straumann solutions at scientific symposium, focusing on patient
Slide 11: Dental Wings, ClearCorrect & Rapid Shape transactions closed
25.10.2017 Strategic priorities of the Straumann Group Drive our high performance STMN Group culture and organization Target unexploited growth markets & segments Expand scope to become a Total Solution Provider for esthetic dentistry 21 Dental Wings, ClearCorrect & Rapid Shape transactions closed O
Slide 12: The orthodontic workflow complements our digital solutions
25.10.2017 The orthodontic workflow complements our digital solutions for esthetic dentistry Case design Treatment design Doctor Doctor approval approval Prosthetic Orthodontic workflow workflow Data capturing Production Aligner Model Tooth-borne implant -borne production production 23 restorations
Slide 13: Outlook 2017
25.10.2017 Outlook for 2017 Barring unforeseen circumstances We expect the global implant market Market growth to grow at approx. 3-4%1 in 2017 Our revenue Confident that we can continue to outperform growth by achieving organic2 revenue growth of 13-15% Further improvements in the underyling2 opera
Slide 14: Calendar of upcoming events; Growth strategy pays off
25.10.2017 Calendar of upcoming events 2017 Event Location 26 October Q3/9M revenue publication Webcast 28 October Investor meetings Paris (F) 31 October Investor meetings Geneva (CH) 16 November Vontobel Healthcare Tour Basel (CH) 17 November Credit Suisse Mid-cap conference Zurich (CH) 23 November
Slide 15: Straumann's currency exposure
25.10.2017 Straumann’s currency exposure Revenue breakdown FY20161 FX sensitivity CHF Average exchange rates (rounded) (+/- 10%) on full-year... Other 8% 15% 9M 2016 9M 2017 Latest trend Revenue EBIT 1 EURCHF 1.09 1.10 +/- 29m +/- 18m BRL 10% 1 USDCHF 0.98 0.98 +/- 23m +/- 11m EUR 31% JPY 100 BR